Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
A Study of the Effect of Multiple Doses of Itraconazole and Fluoxetine on the Pharmacokinetics of a Single Dose of RO5285119 in Healthy Subjects (NCT01967979)Hoffmann-La Roche2013-10-01
Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long Acting GLP-1 Analogue (NNC0113-0987) in Healthy Male Subjects (NCT01967589)Novo Nordisk A/S2013-10-01
Safety of Lymph Node Injection for Allergen Immunotherapy (NCT01982474)Amber Patterson2013-10-01
Dose-Response and Variability of Inhaled Insulin in Type 2 Diabetes (NCT02716610)Dance Biopharm Inc.2013-10-01
Sodium Nitrate to Improve Blood Flow (NCT02847975)Cedars-Sinai Medical Center2013-10-01
Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer (NCT01938573)University of Washington2013-10-01
A First In Human Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Single Oral Doses Of PF-06372865 (NCT01951144)Pfizer2013-10-01
Reactogenicity, Safety and Immunogenicity of a TB/FLU-01L Tuberculosis Vaccine (NCT03017378)Research Institute for Biological Safety Problems2013-10-01
Dendritic Cells for Type 1 Diabetes Mellitus (T1DM) Therapy (NCT01947569)DiaVacs, Inc.2013-10-01
Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma (NCT02248402)Chonnam National University Hospital2013-10-01
Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels (NCT01867255)Mayo Clinic2013-10-01
Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer (NCT01935973)National Cancer Institute (NCI)2013-09-30
A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) (NCT01871805)Hoffmann-La Roche2013-09-30
Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients (NCT02019524)COL George Peoples, MD, FACS2013-09-30
Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery (NCT01947023)National Cancer Institute (NCI)2013-09-27
Pharmacokinetics and Pharmacodynamics of BI 695500 vs. Rituximab as First Line-treatment in Patients With Low Tumor Burden Follicular Lymphoma (NCT01950273)Boehringer Ingelheim2013-09-27
Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer (NCT01938638)Bayer2013-09-26
Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection (NCT01915212)National Institute of Allergy and Infectious Diseases (NIAID)2013-09-26
To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944 (NCT01934205)GlaxoSmithKline2013-09-25
Phase I Study of PH100 (Ecklonia Cava Phlorotannins) (NCT04335045)Phloronol Inc.2013-09-25
Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma (NCT01879085)Melissa Burgess, MD2013-09-24
Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (NCT01955499)National Cancer Institute (NCI)2013-09-24
First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma. (NCT01964287)Institut du Cancer de Montpellier - Val d'Aurelle2013-09-24
To Determine the Effect of Food on the Pharmacokinetics of Olaparib and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid Tumours (NCT01921140)AstraZeneca2013-09-24
Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers (NCT01929330)GlaxoSmithKline2013-09-23
A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) (NCT01911598)Genentech, Inc.2013-09-19
AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia (NCT01798901)Alison Walker2013-09-17
OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma (NCT02368860)National Cancer Centre, Singapore2013-09-17
Intracerebral Gene Therapy in Children With Sanfilippo Type B Syndrome (NCT03300453)UniQure Biopharma B.V.2013-09-17
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease (NCT02218099)Astellas Pharma Europe B.V.2013-09-16
Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment (NCT01830816)Millennium Pharmaceuticals, Inc.2013-09-16
Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma (NCT02025881)Gustave Roussy, Cancer Campus, Grand Paris2013-09-14
Dasatinib, Cytarabine, and Idarubicin in Treating Patients With High-Risk Acute Myeloid Leukemia (NCT01876953)City of Hope Medical Center2013-09-13
A Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid Tumours (NCT01938612)AstraZeneca2013-09-12
A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC) (NCT01920061)Pfizer2013-09-10
Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer (NCT01820325)Novartis Pharmaceuticals2013-09-09
Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies (NCT01947140)Jennifer Amengual2013-09-09
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics (NCT01715844)University of Pittsburgh2013-09-07
The Pharmacokinetics of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Participants With Renal Insufficiency (MK-5172-050) (NCT01937975)Merck Sharp & Dohme LLC2013-09-06
Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer (NCT01857193)Novartis Pharmaceuticals2013-09-06
A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma (NCT01949883)Constellation Pharmaceuticals2013-09-05
BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors (NCT01938846)Boehringer Ingelheim2013-09-05
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma (NCT01938729)Memorial Sloan Kettering Cancer Center2013-09-05
Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas (NCT01922076)National Cancer Institute (NCI)2013-09-03
Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors (NCT01902771)Edward Ziga2013-09-03
Characterization of Exposure From Topical Administration of [14C] Umeclidinium to Axilla or Palm of Healthy Male Subjects (NCT01934153)GlaxoSmithKline2013-09-02
A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies (NCT01844674)Hoffmann-La Roche2013-09-02
Phase I Dose Escalation Study of VS-6063 in Japanese Subjects With Non-Hematologic Malignancies (NCT01943292)Verastem, Inc.2013-09-02
Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor JPN) (NCT01943461)Merck KGaA, Darmstadt, Germany2013-09-02
Acetaminophen's Antinociceptive Effect When Associated With N-Acetylcysteneine (NCT02206178)University Hospital, Clermont-Ferrand2013-09-01
A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer (NCT02005315)OncoMed Pharmaceuticals, Inc.2013-09-01
Chloroquine as an Anti-Autophagy Drug in Stage IV Small Cell Lung Cancer (SCLC) Patients (NCT00969306)Maastricht Radiation Oncology2013-09-01
A Safety and Immunogenicity Phase IB Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid Assessing the Long Term Safety of Previously Treated Subjects (NCT01966224)Immunomic Therapeutics, Inc.2013-09-01
Effect of Ketoconazole on the Pharmacokinetics of Refametinib (NCT01925638)Bayer2013-09-01
Two Vitamin D Dosing Strategies in Children With Chronic Kidney Disease (NCT01909115)Emory University2013-09-01
Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors (NCT01831089)PharmaMar2013-09-01
Clinical Trials on Evaluate the Red Ginseng and Fermented-Red Ginseng Affect to Drug Metabolizing Enzyme and Transporter in Healthy Volunteers (NCT02056743)Chonbuk National University Hospital2013-09-01
Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma (NCT02403544)Chinese Academy of Medical Sciences2013-09-01
A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies (NCT01930552)Sanofi2013-09-01
Safety and Efficacy of Clenbuterol in Individuals With Late-onset Pompe Disease and Receiving Enzyme Replacement Therapy (NCT01942590)Dwight Koeberl, M.D., Ph.D.2013-09-01
A Study to Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With Moderately Diminished Liver Function Compared to Those With Normal Liver Function (NCT02161224)Astellas Pharma Europe B.V.2013-09-01
Lorcaserin for Preventing Weight Gain Among Smokers (NCT02393547)Mayo Clinic2013-09-01
The Influence of Head and Neck Position About Oropharyngeal Leak Pressure and Sealing Between the Laryngeal Mask and Vocal Cord Using Different Types of Supraglottic Airway Device (NCT01960673)National Taiwan University Hospital2013-09-01
Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride (NCT01942551)Dongkook Pharmaceutical Co., Ltd.2013-09-01
Does the Natural Medicinal Plant St John's Wort Affect the Glucose Tolerance in Healthy Individuals (NCT01921881)University of Southern Denmark2013-09-01
Comparative Study of the Bioavailability of Magnesium Administrated by Two ChronoMag Smart Tablet® 50 mg Versus Three Mag2® Tablets 100mg. (NCT01935570)University Hospital, Clermont-Ferrand2013-09-01
Phase I Clinical Human Tolerability Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 (NCT01999231)Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.2013-09-01
A Study to Evaluate the Dose-proportionality and Effects of FG-4592 in Healthy Young and Elderly Male and Female Subjects (NCT02161796)Astellas Pharma Europe B.V.2013-09-01
Multiple Dose Study Of PF-05231023 In Obese Adult Subjects (NCT01923389)Pfizer2013-09-01
Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment (NCT02508740)Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2013-09-01
A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2) Disease (NCT01907087)BioMarin Pharmaceutical2013-09-01
Effect of Photodynamic Therapy With Low-level Laser on Infected Dentin in Primary Teeth: A Controlled Clinical Trial (NCT02734420)University of Nove de Julho2013-09-01
Phase I Study GX-G3 in Healthy Subjects (NCT01951027)Genexine, Inc.2013-09-01
A Phase 1 Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-05230907 In Healthy Volunteers (NCT01897142)Pfizer2013-09-01
A Study of Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC (NCT01957007)OncoMed Pharmaceuticals, Inc.2013-09-01
A Study of Baricitinib and Probenecid in Healthy Participants (NCT01937026)Eli Lilly and Company2013-09-01
Evaluation of Pain and Inflammation After Injection of Lucentis vs Eylea for Treatment of Wet Macular Degeneration (NCT01926977)Arshad Khanani2013-09-01
JetTouch Injection System to Deliver Saline Into the Bladder Wall of Healthy Volunteers (NCT01862601)American Medical Systems2013-09-01
A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors (NCT01949792)Novo Nordisk A/S2013-09-01
Computer Controlled Local Anesthesia in Children (NCT02025140)King Abdulaziz University2013-09-01
Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by Dabigatran (NCT01955720)Boehringer Ingelheim2013-09-01
AZD6423 SAD/MAD Study in Healthy Volunteers (NCT01926366)AstraZeneca2013-09-01
A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female Volunteers (NCT02109185)Mylan Pharmaceuticals Inc2013-09-01
A Study to Test the Safety of Combined Dosing With Aminophylline and Ambrisentan in Exercising Healthy Human Volunteers at Simulated High Altitude (NCT01794078)Robert J Noveck, M.D.2013-09-01
Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults (NCT01717950)Baylor College of Medicine2013-09-01
Influence of Hepatic Impairment on Pharmacokinetic (PK) and Pharmacodynamic (PD) of Gemigliptin PK and PD After Multiple Oral Doses in Healthy White Volunteers (NCT02004587)LG Life Sciences2013-09-01
A Phase Ib Study of the Safety, Tolerability and Efficacy of LY2780301 in Combination With Gemcitabine (NCT02018874)Gustave Roussy, Cancer Campus, Grand Paris2013-09-01
A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer (NCT01973309)OncoMed Pharmaceuticals, Inc.2013-09-01
Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study (NCT01944371)University of California, San Francisco2013-09-01
Muscle Afferent Feedback Effects in Patients With Heart Failure (NCT01919918)University of Utah2013-09-01
Racecadotril Suspension Linearity Study & Comparative Bioavailability Versus Granules (NCT01948011)Bioprojet2013-09-01
Chemotherapy for Patients With Cancer of the Stomach (NCT01928524)Per Pfeiffer2013-09-01
A Vasoconstriction Study With LEO 90100 (NCT01946386)LEO Pharma2013-09-01
Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery (NCT01888302)Mayo Clinic2013-09-01
Temsirolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT01902160)National Cancer Institute (NCI)2013-09-01
An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies (NCT01929941)Incyte Corporation2013-09-01
Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male Volunteers (NCT01964365)Daewoong Pharmaceutical Co. LTD.2013-09-01
Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation (NCT01178216)Stanley Jordan, MD2013-09-01
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO) (NCT01913340)University of California, San Francisco2013-09-01
Nasally and sc Administered Teriparatide in Healthy Volunteers (NCT01913834)Nottingham University Hospitals NHS Trust2013-09-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.